Imed Infinity Medical-Limited Partnership
IMED.TA - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$584.22M
Close$
$197.40
130.6% upside
Current Fair Value
130.6% upsideUndervalued by 130.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $584.22 Million |
|---|---|
| Enterprise Value | $581.48 Million |
| Earnings per Share | $-0.03 |
| Beta | 0.3 |
| Outstanding Shares | 6,825,000 |
Return
| Return on Equity | -4.09% |
|---|---|
| Return on Assets | -3.23% |
| Return on Invested Capital | -7.04% |
Valuation & Multiples
| P/E Ratio | -3.19 |
|---|---|
| PEG | 2.8 |
| Price to Sales | - |
| Price to Book Ratio | 85.6 |
| Enterprise Value to Revenue | 710.86 |
| Enterprise Value to EBIT | -1049.97 |
| Enterprise Value to Net Income | -2284 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Imed Infinity Medical-Limited Partnership
70 employees
CEO: Itay Gal-Or
Operating as a research and development partnership, Imed Infinity Medical-Limited Partnership was founded in 2020 and is located in Tel Aviv, Israel. Its central mission involves providing capital for R&D ventures within the medical domain, especially those focused on digital health.